Research progress on fecal microbiota transplantation for the treatment of hypertension
10.3969/j.issn.1006-5725.2025.19.025
- VernacularTitle:肠道菌群在高血压治疗中的研究进展
- Author:
Yilin HUANG
1
;
Shuang LI
;
Zhengyong HE
;
Zeyu ZHANG
Author Information
1. 南昌大学创伤医学研究所,创烧伤及疼痛江西省重点实验室,急诊外科,第一附属医院,江西医学院,南昌大学(江西 南昌 330006);焕奎书院,江西医学院,南昌大学(江西 南昌 330031)
- Publication Type:Journal Article
- Keywords:
gut microbiota;
hypertension;
fecal microbiota transplantation
- From:
The Journal of Practical Medicine
2025;41(19):3129-3134
- CountryChina
- Language:Chinese
-
Abstract:
Hypertension is an important risk factor that causes cardiovascular diseases and premature death in China.The pathogenesis of hypertension is complex and affected by numerous factors.Gut microbiota are involved in regulating many physiological processes of human body,making it a key factor in human health.Many studies have shown that there are close relationships between gut microbiota dysbiosis and the onset and progression of hyper-tension.Restoring gut microbiota homeostasis can reduce blood pressure.Thus,gut microbiota has become a poten-tial therapeutic target for hypertension.Therefore,this article mainly reviews the connection between gut microbiota and hypertension,as well as the study progress of adjusting gut microbiota homeostasis for the prevention and treat-ment of hypertension.
